Sunny Patel, DO | |
100 N Academy Ave, Danville, PA 17822-0001 | |
(570) 271-6439 | |
(570) 271-6852 |
Full Name | Sunny Patel |
---|---|
Gender | Male |
Speciality | Internal Medicine - Gastroenterology |
Location | 100 N Academy Ave, Danville, Pennsylvania |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1780045906 | NPI | - | NPPES |
Entity Name | Geisinger Clinic |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1366493868 PECOS PAC ID: 5395657001 Enrollment ID: O20040130000518 |
News Archive
Researchers at the Moffitt Cancer Center have found a potential mechanism by which immune suppressive myeloid-derived suppressor cells can prevent immune response from developing in cancer.
Cardiac marker POC tests are now widely used in hospitals and have emerged as a successful model of the concept of point-of-care diagnostics, according to a new report from Kalorama Information. The 2008 world market for POC cardiac enzymes and tests is estimated at $490 million, and growing at 12% a year for the past three years, according to "Point of Care Diagnostics 2010 and Beyond: Rapid Testing at a Crossroads," from healthcare market research publisher Kalorama Information.
Congress needs to make sure that lobbying -; and every dollar of campaign contributions to the super committee's members -; is fully and immediately disclosed. ... The American Hospital Association has vowed a "full-court press" on the committee, as have defense industries and others.
A three-drug treatment for the blood cancer multiple myeloma provided rapid, deep and potentially durable responses, researchers report today online in Blood, the Journal of the American Society of Hematology, and yesterday, Sunday, June 3, 2012, at the American Society of Clinical Oncology's Annual Meeting in Chicago, IL, USA.
AVEO Pharmaceuticals, Inc., a biopharmaceutical company focused on discovering, developing and commercializing cancer therapeutics, today provided an update on recent research and development (R&D) and business accomplishments, and announced financial results for the quarter ended June 30, 2010.
› Verified 1 days ago
Entity Name | Evangelical Medical Services Organization |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1295834984 PECOS PAC ID: 9133033087 Enrollment ID: O20040310000212 |
News Archive
Researchers at the Moffitt Cancer Center have found a potential mechanism by which immune suppressive myeloid-derived suppressor cells can prevent immune response from developing in cancer.
Cardiac marker POC tests are now widely used in hospitals and have emerged as a successful model of the concept of point-of-care diagnostics, according to a new report from Kalorama Information. The 2008 world market for POC cardiac enzymes and tests is estimated at $490 million, and growing at 12% a year for the past three years, according to "Point of Care Diagnostics 2010 and Beyond: Rapid Testing at a Crossroads," from healthcare market research publisher Kalorama Information.
Congress needs to make sure that lobbying -; and every dollar of campaign contributions to the super committee's members -; is fully and immediately disclosed. ... The American Hospital Association has vowed a "full-court press" on the committee, as have defense industries and others.
A three-drug treatment for the blood cancer multiple myeloma provided rapid, deep and potentially durable responses, researchers report today online in Blood, the Journal of the American Society of Hematology, and yesterday, Sunday, June 3, 2012, at the American Society of Clinical Oncology's Annual Meeting in Chicago, IL, USA.
AVEO Pharmaceuticals, Inc., a biopharmaceutical company focused on discovering, developing and commercializing cancer therapeutics, today provided an update on recent research and development (R&D) and business accomplishments, and announced financial results for the quarter ended June 30, 2010.
› Verified 1 days ago
Entity Name | Geisinger-hm Joint Venture Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1144876137 PECOS PAC ID: 1355676370 Enrollment ID: O20190826000803 |
News Archive
Researchers at the Moffitt Cancer Center have found a potential mechanism by which immune suppressive myeloid-derived suppressor cells can prevent immune response from developing in cancer.
Cardiac marker POC tests are now widely used in hospitals and have emerged as a successful model of the concept of point-of-care diagnostics, according to a new report from Kalorama Information. The 2008 world market for POC cardiac enzymes and tests is estimated at $490 million, and growing at 12% a year for the past three years, according to "Point of Care Diagnostics 2010 and Beyond: Rapid Testing at a Crossroads," from healthcare market research publisher Kalorama Information.
Congress needs to make sure that lobbying -; and every dollar of campaign contributions to the super committee's members -; is fully and immediately disclosed. ... The American Hospital Association has vowed a "full-court press" on the committee, as have defense industries and others.
A three-drug treatment for the blood cancer multiple myeloma provided rapid, deep and potentially durable responses, researchers report today online in Blood, the Journal of the American Society of Hematology, and yesterday, Sunday, June 3, 2012, at the American Society of Clinical Oncology's Annual Meeting in Chicago, IL, USA.
AVEO Pharmaceuticals, Inc., a biopharmaceutical company focused on discovering, developing and commercializing cancer therapeutics, today provided an update on recent research and development (R&D) and business accomplishments, and announced financial results for the quarter ended June 30, 2010.
› Verified 1 days ago
Mailing Address | Practice Location Address |
---|---|
Sunny Patel, DO 100 N Academy Ave, Danville, PA 17822-4903 Ph: (570) 271-6144 | Sunny Patel, DO 100 N Academy Ave, Danville, PA 17822-0001 Ph: (570) 271-6439 |
News Archive
Researchers at the Moffitt Cancer Center have found a potential mechanism by which immune suppressive myeloid-derived suppressor cells can prevent immune response from developing in cancer.
Cardiac marker POC tests are now widely used in hospitals and have emerged as a successful model of the concept of point-of-care diagnostics, according to a new report from Kalorama Information. The 2008 world market for POC cardiac enzymes and tests is estimated at $490 million, and growing at 12% a year for the past three years, according to "Point of Care Diagnostics 2010 and Beyond: Rapid Testing at a Crossroads," from healthcare market research publisher Kalorama Information.
Congress needs to make sure that lobbying -; and every dollar of campaign contributions to the super committee's members -; is fully and immediately disclosed. ... The American Hospital Association has vowed a "full-court press" on the committee, as have defense industries and others.
A three-drug treatment for the blood cancer multiple myeloma provided rapid, deep and potentially durable responses, researchers report today online in Blood, the Journal of the American Society of Hematology, and yesterday, Sunday, June 3, 2012, at the American Society of Clinical Oncology's Annual Meeting in Chicago, IL, USA.
AVEO Pharmaceuticals, Inc., a biopharmaceutical company focused on discovering, developing and commercializing cancer therapeutics, today provided an update on recent research and development (R&D) and business accomplishments, and announced financial results for the quarter ended June 30, 2010.
› Verified 1 days ago
Dr. Stanley Joseph Russin, M.D. Gastroenterology Medicare: Not Enrolled in Medicare Practice Location: 100 N Academy Ave, Danville, PA 17822 Phone: 570-214-9585 Fax: 570-214-9519 | |
Dr. Steven Bonebrake, D.O. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 100 N Academy Ave, Danville, PA 17822 Phone: 570-271-5555 Fax: 570-271-5269 | |
Tatiana Parra, Gastroenterology Medicare: Medicare Enrolled Practice Location: 100 N Academy Ave, Danville, PA 17822 Phone: 570-271-6164 Fax: 570-271-6141 | |
Dr. Paul Flavian Simonelli, MD, PH.D. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 100 N Academy Ave, Mc 01-11, Danville, PA 17822 Phone: 570-271-6655 Fax: 570-214-3967 | |
Dr. Taher M. Yahya, M.D. Gastroenterology Medicare: Not Enrolled in Medicare Practice Location: 100 N Academy Ave, Danville, PA 17822 Phone: 570-271-6393 Fax: 570-271-5623 | |
Dr. Ion D. Bucaloiu, M.D. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 100 N Academy Ave, Danville, PA 17822 Phone: 570-271-6164 Fax: 570-271-6141 | |
Dr. Mark A Shelly, M.D. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 100 N Academy Ave, Danville, PA 17822 Phone: 570-271-6408 Fax: 570-271-5845 |